Propolis supplementation AND Coronavirus

Phase 2

Recruiting

• Conditions: covid 19.; Covid-19; U07.1

• Registration Number: IRCT20200802048267N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

A willing to participate with written informed consent
The diagnosis of coronavirus based on the PCR test.

Exclusion Criteria

Current use of warfarin
Current use of Propolis Supplement
Presence of sensitivity to bee products

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Erythrocyte Sedimentation Rate. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Severity and number of coughs. Timepoint: Day 1 and day 14. Method of measurement: Cough visual analogue scale (VAS).;Respiratory Rate. Timepoint: day 1 and day 14. Method of measurement: The number of breaths a person takes per minute.;Chest CT scan. Timepoint: Day 1 and day 14. Method of measurement: X ray imaging.;High-sensitivity C-reactive protein. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.

Secondary Outcome Measures

Name	Time	Method
Body temperature. Timepoint: Day 1 and day 14. Method of measurement: Clinical Thermometer.;Alanine aminotransferase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Aspartate aminotransferase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Superoxide dismutase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Albumin. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.